SEER · Seer, Inc. · Stock research

Current Thesis

Seer is a contested control situation with a hard date attached. Between 2026-07-01 and 2026-07-30 the company received four escalating non-binding take-private proposals from two separate bidders: Chair/CEO Omid Farokhzad at $2.45 per Class A share in cash plus two contingent value rights, and the Radoff-JEC Group (Bradley Radoff and Michael Torok, ~7.7% holders) at $2.55 per Class A share in cash plus one CVR. The target reported approximately $220M of cash, cash equivalents and investments at 2026-03-31 against roughly 54.98M shares outstanding as of 2026-07-25 — both standing bids value the equity materially below that reported cash position. Radoff-JEC stated on 2026-07-28 that its proposal is "not subject to any financing conditions" and does not expire until 2026-08-10. The stock closed 2026-08-07 at $2.17, below the $2.55 proposal and below the $2.37 52-week high. The market is pricing meaningful doubt that either bid closes.

Bullish and bearish views on Seer, Inc.

The model's bull view on Seer, Inc. (SEER), in brief: 2026-07-30: Seer confirmed receipt of both revised proposals and said the Special Committee, with Perella Weinberg Partners as financial advisor and Wilson Sonsini as legal counsel, would review "both acquisition proposals and other alternatives." That mandate is broader than… The bear view: The activist's governance lever failed on 2026-07-28. Both cases follow in full.

Bull Case

• 2026-07-30: Seer confirmed receipt of both revised proposals and said the Special Committee, with Perella Weinberg Partners as financial advisor and Wilson Sonsini as legal counsel, would review "both acquisition proposals and other alternatives." That mandate is broader than the flat rejection language issued ten days earlier.
• 2026-07-28: Radoff-JEC raised from an earlier level to $2.55 cash plus a CVR paying 85% of net proceeds from any license, sale or other disposition of Seer's business and assets, including PrognomiQ, with payments expected within six to twelve months post-closing. The group described $2.55 as a 51% premium to the unaffected share price.
• Two independent bidders are live simultaneously. The price ladder moved from the $2.45 CEO proposal of 2026-07-01 to $2.55 on 2026-07-28 inside 27 days — an auction dynamic, and the Special Committee retains the ability to run one.
• Balance sheet backstop: ~$220M cash, equivalents and investments at 2026-03-31 (Q1 2026 results). Even after two quarters of burn, the reported cash line is the anchor both bidders are negotiating against.
• INFERRED, not measured: the 2026-07-20 rejection language ("undervalues Seer and does not reflect its long-term growth prospects") is consistent with a negotiation over price rather than a refusal to transact. Nothing in the public record confirms the Committee will accept any number.

Bear Case

• The activist's governance lever failed on 2026-07-28. Stockholders re-elected all seven company nominees — Farokhzad, Gulyani, Langer, McGuire, Nishar, Ro and Roelofs. The Radoff-JEC WHITE-card slate of three did not get seated. The pressure channel that forces a sale narrowed the same week the bid was raised.
• Dual-class mechanics. Class B common carries ten votes per share and converts 1:1 into Class A; both proposals are for Class A shares only. Economic ownership and voting control are not the same register here.
• Operating trend is deteriorating. Q1 2026 revenue was $2.8M, down 34% from $4.2M a year earlier. FY2026 guidance was reaffirmed at $16–18M.
• Neither proposal is binding and no definitive agreement exists. The CVR component in both structures carries no disclosed floor value; a reader cannot mark it.
• Consensus for the 2026-08-11 Q2 print is -$0.27 EPS on $3.55M revenue (estimates compiled by Daily Political, 2026-07-29). Cash consumed between 2026-03-31 and 2026-06-30 lowers the number the whole case rests on.
• Radoff-JEC's own 2026-07-23 solicitation cited a roughly 97% share-price decline since the 2020 IPO — the standalone track record the Committee is asking holders to underwrite.

Setup & Price Structure

• 52-week high $2.37, so -8.4%. RSI(14) 59.4. Three-month return +16.0%.
• The highest standing proposal, $2.55, sits above the 52-week high. The equity has not traded at the offer at any point in the past year; the 2026-08-07 close is a mid-teens percentage discount to that bid. For a cash proposal explicitly stated to carry no financing condition, that spread is a direct read on perceived closure risk.
• Reaction decay is the structural observable. The first proposal produced a 32.1% pre-market move to $2.14 on 2026-07-06, with SEER appearing that morning in Benzinga's healthcare-movers screens. The higher 2026-07-28 bid and the 2026-07-30 dual-proposal confirmation did not establish a new sustained high; price sits under $2.37 with RSI below 60.
• Life-cycle: MATURING. Fully public since the 2026-07-06 gap, still working (+16.0% over three months), but each successive escalation has drawn a smaller price response, and the governance catalyst that opened the story resolved against the challenger on 2026-07-28.
• Crowding and positioning observables: ~7.7% of shares concentrated in the bidding group per its 2026-07-28 statement; screen-driven retail coverage clustered on 2026-07-06 (multiple "stocks moving" lists the same session); an earnings date four calendar days after the price basis; no insider open-market transactions surfaced in the last 30 days of filings; no equity issuance announced into the July strength.

Catalyst Calendar (next 30 days)

• 2026-08-10 — Radoff-JEC $2.55 cash + CVR proposal expires by its own stated terms. Either extended, accepted, countered, or lapsed.
• 2026-08-11 — Q2 2026 financial results; conference call 1:30 p.m. PT / 4:30 p.m. ET. Updated cash balance and FY2026 revenue guidance.
• 2026-08-12 — Canaccord Genuity 46th Annual Growth Conference, management presentation 8:00–8:25 a.m. ET.
• ~2026-08-11 to 2026-08-17 (est.) — Q2 10-Q filing: updated cash line, share counts by class, and any subsequent-events language on the proposals.
• Undated, any session — a Special Committee response to either revised proposal, or announcement of a formal strategic review process.

What Would Change Our Mind

The structural break is 2026-08-10 arriving with the Radoff-JEC proposal lapsing unextended and no Special Committee counter. At that point the only bid on the table is the $2.45 the Committee already rejected on 2026-07-20, from a bidder who also chairs the board, and the premium loses its anchor. On price, a daily close below $1.95 gives back the shelf built after the 2026-07-06 gap and argues the tape is re-marking toward the unaffected level Radoff-JEC characterised as 51% below its $2.55 offer. A second, independent break: a Q2 print on 2026-08-11 showing cash materially below the ~$220M reported at 2026-03-31, or an FY2026 guidance cut from the reaffirmed $16–18M range — either removes the balance-sheet floor the entire case is built on. Confirmation the other way would be a definitive merger agreement, a formal strategic-review announcement, or a third bidder appearing in an 8-K.

Correlation Notes

• During an active bid process, daily variance is driven by Special Committee and bidder statements rather than the life-science-tools tape. Expect low beta to XBI and to the research-instruments complex until the process resolves.
• Peer complex: Quantum-Si, Nautilus Biotechnology, Standard BioTools, 10x Genomics — sub-scale proteomics and tools names where several trade near or below reported cash. A broad re-rating of that group changes the "equity below cash" framing across all of them at once, including here.
• Academic and biopharma research budgets set the revenue trajectory that the standalone case depends on; FY2026 guidance is $16–18M against Q1 revenue of $2.8M.
• Only Class A is exchange-traded and both proposals address Class A only; the ten-vote Class B means the public tape does not carry voting control.
• Micro-cap float and screen-driven headline flow mean single-session moves on non-fundamental coverage should be treated as liquidity events rather than information.